| Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial RD McBane II, WE Wysokinski, JG Le‐Rademacher, T Zemla, A Ashrani, ... Journal of thrombosis and haemostasis 18 (2), 411-421, 2020 | 592 | 2020 |
| Reversal of the estrogen receptor–negative phenotype in breast cancer and restoration of antiestrogen response J Bayliss, A Hilger, P Vishnu, K Diehl, D El-Ashry Clinical Cancer Research 13 (23), 7029-7036, 2007 | 151 | 2007 |
| Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer P Vishnu, V Roy Breast Cancer: Basic and Clinical Research 5, BCBCR. S5857, 2011 | 123 | 2011 |
| Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma G Chen, X Wang, J Yu, S Varambally, J Yu, DG Thomas, MY Lin, P Vishnu, ... Cancer research 67 (7), 3461-3467, 2007 | 114 | 2007 |
| Haematological manifestations of human immune deficiency virus infection P Vishnu, DM Aboulafia British journal of haematology 171 (5), 695-709, 2015 | 107 | 2015 |
| TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort J Hong, E Leung, AG Fraser, TR Merriman, P Vishnu, GW Krissansen Journal of gastroenterology and hepatology 22 (11), 1760-1766, 2007 | 104 | 2007 |
| Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia V Kumar, S Ailawadhi, L Bojanini, A Mehta, S Biswas, T Sher, V Roy, ... Blood cancer journal 9 (10), 75, 2019 | 75 | 2019 |
| Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort E Leung, J Hong, AG Fraser, TR Merriman, P Vishnu, GW Krissansen Immunology and Cell Biology 84 (2), 233-236, 2006 | 74 | 2006 |
| Diagnosis and management of genetic iron overload disorders WC Palmer, P Vishnu, W Sanchez, B Aqel, D Riegert-Johnson, ... Journal of general internal medicine 33, 2230-2236, 2018 | 67 | 2018 |
| Efficacy and cost‐benefit analysis of risk‐adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization P Vishnu, V Roy, A Paulsen, AC Zubair Transfusion 52 (1), 55-62, 2012 | 67 | 2012 |
| COVID-19 vaccination associated severe immune thrombocytopenia SRA Shah, S Dolkar, J Mathew, P Vishnu Experimental Hematology & Oncology 10, 1-5, 2021 | 60 | 2021 |
| Update on options for treatment of metastatic castration-resistant prostate cancer P Vishnu, WW Tan OncoTargets and Therapy, 39-51, 2010 | 59 | 2010 |
| Current therapeutic strategies for invasive and metastatic bladder cancer P Vishnu, J Mathew, WW Tan OncoTargets and therapy, 97-113, 2011 | 56 | 2011 |
| AIDS‐Related Non‐Hodgkin′ s Lymphoma in the Era of Highly Active Antiretroviral Therapy P Vishnu, DM Aboulafia Advances in hematology 2012 (1), 485943, 2012 | 47 | 2012 |
| Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia P Vishnu, DM Aboulafia Journal of Blood Medicine, 99-106, 2016 | 36 | 2016 |
| Incidence of skin and respiratory immune-related adverse events correlates with specific tumor types in patients treated with checkpoint inhibitors LM Rose, HA DeBerg, P Vishnu, JK Frankel, AB Manjunath, JPE Flores, ... Frontiers in Oncology 10, 570752, 2021 | 34 | 2021 |
| Elevated neutrophil-lymphocyte ratio is predictive of poor outcomes following aneurysmal subarachnoid hemorrhage SA Jamali, MT Turnbull, T Kanekiyo, P Vishnu, AC Zubair, CC Raper, ... Journal of Stroke and Cerebrovascular Diseases 29 (4), 104631, 2020 | 32 | 2020 |
| Sudden blastic transformation in treatment‐free remission chronic myeloid leukaemia. M Alfayez, G Richard‐Carpentier, E Jabbour, P Vishnu, K Naqvi, K Sasaki, ... British Journal of Haematology 187 (4), 2019 | 30 | 2019 |
| Utility of bone marrow biopsy and aspirate for staging of diffuse large B cell lymphoma in the era of positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro … P Vishnu, A Wingerson, M Lee, MT Mandelson, DM Aboulafia Clinical Lymphoma Myeloma and Leukemia 17 (10), 631-636, 2017 | 30 | 2017 |
| Hepatic iron overload identified by magnetic resonance imaging-based T2* is a predictor of non-diagnostic elastography HM Ghoz, PT Kröner, FF Stancampiano, AW Bowman, P Vishnu, ... Quantitative imaging in medicine and surgery 9 (6), 921, 2019 | 29 | 2019 |